Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

AIMS: While mineralocorticoid receptor antagonists (MRAs) have been shown to benefit patients with reduced left ventricular ejection fraction (LVEF), spironolactone did not reduce the primary endpoint of cardiovascular death, heart failure hospitalization, or aborted cardiac arrest in patients with...

詳細記述

保存先:
書誌詳細
出版年:Eur Heart J
主要な著者: Solomon, Scott D., Claggett, Brian, Lewis, Eldrin F., Desai, Akshay, Anand, Inder, Sweitzer, Nancy K., O'Meara, Eileen, Shah, Sanjiv J., McKinlay, Sonja, Fleg, Jerome L., Sopko, George, Pitt, Bertram, Pfeffer, Marc A.
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2016
主題:
Clinical Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4751235/
https://ncbi.nlm.nih.gov/pubmed/26374849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv464
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料